EMPLOYMENT TYPE MIX · DOL LCA DATA

Regeneron Pharmaceuticals, Inc. H-1B New Employment

Of Regeneron Pharmaceuticals, Inc.'s 617 certified H-1B filings with a stated employment type (FY2021–2026), 30.8% are new employment at a median of $135K/year. The rest are extensions, transfers and amendments for workers already sponsored.

30.8%
New Employment
190
New-Hire Filings
$135K
Median, New Hires
$155K
Median, Renewals

Is Regeneron Pharmaceuticals, Inc. Hiring New H-1B Workers?

Yes. At 30.8%, Regeneron Pharmaceuticals, Inc. files a high share of genuinely new H-1B employment, so a meaningful part of its sponsorship goes to people it has not sponsored before. That is the population an outside applicant joins.

Employment Type Breakdown at Regeneron Pharmaceuticals, Inc.

New employmentA worker not already on H-1B with this employer, the route in from outside
190 filings · 30.8%
Continuation / extensionExtending an existing H-1B for someone already on staff
118 filings · 19.1%
Change of employerTaking on a worker who already holds H-1B elsewhere
88 filings · 14.3%
Amended petitionChanging the terms of an existing petition, such as a new work site
30 filings · 4.9%
Change at same employerA material change to the same worker's existing role
191 filings · 31%
Concurrent employmentA second, simultaneous H-1B alongside another employer
0 filings · 0%

Bars are scaled to this employer's largest category, not to 100%. Percentages are of Regeneron Pharmaceuticals, Inc.'s 617 certified filings that state an employment type. A small number of filings tick more than one box, so the shares can total slightly above 100%.

Is That Share Rising or Falling?

FY2022
52.7% of 55
FY2023
2% of 50
FY2024
30.9% of 152
FY2025
27.6% of 145
FY2026
34% of 215

New-employment share per fiscal year, each against that year's filings with a stated type. Bars are scaled to this employer's peak year.

What Roles Is Regeneron Pharmaceuticals, Inc. Hiring Into?

Job titles on Regeneron Pharmaceuticals, Inc.'s new-employment filings specifically, which is what it is actually growing rather than merely maintaining.

RoleNew-Hire FilingsMedian Wage
Biochemists and Biophysicists43$134K
Medical Scientists, Except Epidemiologists21$115K
Molecular and Cellular Biologists19$115K
Chemists16$104K
Biological Technicians12$85K
Biostatisticians10$151K
Bioinformatics Scientists10$146K
Bioengineers and Biomedical Engineers8$139K

Why This Number Matters

Total sponsorship volume is the figure most job boards quote, and on its own it is misleading. An employer filing thousands of petitions a year can be filing almost all of them to extend people it sponsored years ago, which tells an outside applicant very little about their odds.

The new-employment share separates the two. It is the employer's own checkbox on the Labor Condition Application, not an estimate, and it identifies the filings that represent someone entering the company rather than staying in it.

More on Regeneron Pharmaceuticals, Inc.

Related

Job Alert Pro

âš¡ Never miss an H1B job again

Get instant email alerts for new H1B jobs matching your skills, location, and seniority level. Our system scans 130+ companies daily and notifies you before jobs fill up.

  • ✓ Real-time job matching (alerts within minutes of posting)
  • ✓ Verified H1B sponsors only (100% sponsorship history verified)
  • ✓ Mobile app notifications (never miss a job)
  • ✓ Advanced filters (location, salary, seniority, role)
  • ✓ Cancel anytime (no long-term commitment)
$25/mo
Start Free Trial
HJ

H1B Visa Jobs Research Team

Counted from US Department of Labor LCA disclosure files (FY2021–2026) for certified petitions filed by Regeneron Pharmaceuticals, Inc. with annual wages between $30K and $1M. Shares are of the 617 filings that tick at least one employment-type box; the remaining 24.3% of Regeneron Pharmaceuticals, Inc.'s 815 certified filings state no type and are excluded rather than counted as renewals. A certified LCA is a step toward an H-1B petition, not an approved visa.